CN103393623A - 新型制剂 - Google Patents

新型制剂 Download PDF

Info

Publication number
CN103393623A
CN103393623A CN2013102428866A CN201310242886A CN103393623A CN 103393623 A CN103393623 A CN 103393623A CN 2013102428866 A CN2013102428866 A CN 2013102428866A CN 201310242886 A CN201310242886 A CN 201310242886A CN 103393623 A CN103393623 A CN 103393623A
Authority
CN
China
Prior art keywords
preparation
drug level
blood drug
effective ingredient
level persistence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013102428866A
Other languages
English (en)
Chinese (zh)
Inventor
今田康嗣
新海康成
井墉松男
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp
Publication of CN103393623A publication Critical patent/CN103393623A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
CN2013102428866A 2007-11-09 2008-11-07 新型制剂 Pending CN103393623A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007291570 2007-11-09
JP2007-291570 2007-11-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN200880115418A Division CN101854929A (zh) 2007-11-09 2008-11-07 新型制剂

Publications (1)

Publication Number Publication Date
CN103393623A true CN103393623A (zh) 2013-11-20

Family

ID=40625838

Family Applications (3)

Application Number Title Priority Date Filing Date
CN2013102428866A Pending CN103393623A (zh) 2007-11-09 2008-11-07 新型制剂
CN201510050252.XA Pending CN104739819A (zh) 2007-11-09 2008-11-07 新型制剂
CN200880115418A Pending CN101854929A (zh) 2007-11-09 2008-11-07 新型制剂

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN201510050252.XA Pending CN104739819A (zh) 2007-11-09 2008-11-07 新型制剂
CN200880115418A Pending CN101854929A (zh) 2007-11-09 2008-11-07 新型制剂

Country Status (4)

Country Link
JP (2) JP5479909B2 (ja)
KR (1) KR101122447B1 (ja)
CN (3) CN103393623A (ja)
WO (1) WO2009060952A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104739752A (zh) * 2014-12-08 2015-07-01 济南齐拓医药科技有限公司 一种新型的盐酸沙格雷酯缓释制剂

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2797809A1 (en) 2010-04-30 2011-11-03 Takeda Pharmaceutical Company Limited Enteric tablet
CN101933918A (zh) * 2010-09-08 2011-01-05 苏州世林医药技术发展有限公司 盐酸沙格雷酯缓释制剂及制备方法
CN102552165B (zh) * 2012-01-05 2014-07-16 金陵药业股份有限公司 一种盐酸沙格雷酯缓释微丸及其制备方法
FR2986431B1 (fr) * 2012-02-03 2017-03-17 Servier Lab Composition pharmaceutique a liberation prolongee de trimetazidine, son procede de fabrication et son utilisation dans des traitements therapeutiques
KR101184725B1 (ko) 2012-04-04 2012-09-20 주식회사 셀트리온제약 사포그릴레이트를 포함하는 간섬유화 또는 간경변의 치료 또는 예방용 약제학적 조성물
EP3845219A4 (en) * 2018-08-28 2022-06-08 Towa Pharmaceutical Co., Ltd. ACTIVE PARTICLE
JP7315383B2 (ja) * 2019-06-27 2023-07-26 株式会社Ｓｃｒｅｅｎホールディングス インクジェット用水性組成物及び固体製剤
CN111944529B (zh) * 2020-08-25 2021-09-14 武汉药谷生物工程有限公司 碳酸氢钠注射液包装用碳酸氢钠缓释片

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072942A2 (en) * 1981-08-20 1983-03-02 Mitsubishi Kasei Corporation Pharmaceutically active (3-aminopropoxy)-bibenzyl derivatives
WO2007036671A2 (fr) * 2005-09-30 2007-04-05 Flamel Technologies Microparticules enrobees a liberation modifiee d ' au moins un principe actif et forme galenique orale en comprenant

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001055322A (ja) * 1999-08-18 2001-02-27 Tanabe Seiyaku Co Ltd パルス放出型製剤
JP2001139462A (ja) * 1999-11-10 2001-05-22 Dai Ichi Seiyaku Co Ltd 新規製剤
JP2002212062A (ja) * 2001-01-24 2002-07-31 Teijin Ltd 遅延放出制御組成物
JP5073891B2 (ja) * 2001-07-16 2012-11-14 川澄化学工業株式会社 ステント及びステントグラフト
EP1430890A4 (en) * 2001-09-26 2007-01-17 Mitsubishi Pharma Corp THROMBUS / THROMBOGENESIS INHIBITORS
JP4936420B2 (ja) * 2005-08-02 2012-05-23 塩野義製薬株式会社 徐放性顆粒剤
JP5153340B2 (ja) * 2005-11-16 2013-02-27 学校法人東海大学 薬剤放出制御組成物および薬剤放出性医療器具

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072942A2 (en) * 1981-08-20 1983-03-02 Mitsubishi Kasei Corporation Pharmaceutically active (3-aminopropoxy)-bibenzyl derivatives
WO2007036671A2 (fr) * 2005-09-30 2007-04-05 Flamel Technologies Microparticules enrobees a liberation modifiee d ' au moins un principe actif et forme galenique orale en comprenant

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104739752A (zh) * 2014-12-08 2015-07-01 济南齐拓医药科技有限公司 一种新型的盐酸沙格雷酯缓释制剂

Also Published As

Publication number Publication date
KR101122447B1 (ko) 2012-03-20
WO2009060952A1 (ja) 2009-05-14
JP2014040475A (ja) 2014-03-06
CN101854929A (zh) 2010-10-06
JP5479909B2 (ja) 2014-04-23
KR20100096147A (ko) 2010-09-01
JPWO2009060952A1 (ja) 2011-03-24
CN104739819A (zh) 2015-07-01

Similar Documents

Publication Publication Date Title
CN103393623A (zh) 新型制剂
JP4879351B2 (ja) 医薬固形製剤
JP5054000B2 (ja) イマチニブおよび放出遅延剤を含む医薬組成物
JP5834052B2 (ja) 制御放出ヒドロコドン処方
CN100563658C (zh) 苯丙氨酸衍生物的固体分散体或固体分散体医药制剂
KR101151117B1 (ko) 경구 투여가능한 고체 제약 조성물의 제조 방법
CN101636152B (zh) 含有西洛他唑的控释制剂及其制备方法
EP1957048A2 (de) Feste, oral applizierbare pharmazeutische darreichungsformen mit schneller wirkstofffreisetzung
JP2003514019A (ja) カルベジロールメタンスルホン酸塩
CN102170870A (zh) 恩他卡朋或其盐的缓释药物组合物
JP2002521315A (ja) 経口用固体剤形のエプロサルタン配合の生体内強化性処方
CN109078015A (zh) 食欲素受体拮抗剂的固体剂量制剂
WO2008064202A2 (en) Modified-release formulations of calcium receptor-active compounds
JP2002526437A (ja) アジテーション非依存性薬学的マルチプル−ユニット持効性製剤およびその製法
US20100136119A1 (en) Controlled-release preparation containing cilostazol and process for the preparation thereof
TW200848056A (en) Solid dispersion of a neurokinin antagonist
JP2010540547A (ja) アリスキレンおよびバルサルタンのガレヌス製剤
JP2012503665A (ja) アリスキレンを含むガレヌス製剤および溶融押出し造粒によるその調製方法
CA2899389C (en) Solid dispersion comprising amorphous cilostazol
JP2015071556A (ja) 錠剤及びその製造方法
WO2019030691A1 (en) EXTRUDED COMPOSITIONS OF ENZALUTAMIDE
JP2602515B2 (ja) 球形顆粒剤
WO2019209208A2 (en) Controlled-release pharmaceutical compositions of ivabradine
TW201609197A (zh) 每日一次投藥之提供藥學及臨床效果之莫沙必利持續釋放製劑

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20131120